Aspir-Mox IB Interactions
There are 657 drugs known to interact with Aspir-Mox IB (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide), along with 18 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 71 are major, 522 are moderate, and 64 are minor.
- View all 657 medications that may interact with Aspir-Mox IB
- View Aspir-Mox IB alcohol/food interactions (4)
- View Aspir-Mox IB disease interactions (18)
Most frequently checked interactions
View interaction reports for Aspir-Mox IB (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide) and the medicines listed below.
- Actos (pioglitazone)
- Advair Diskus (fluticasone / salmeterol)
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- bisoprolol
- bupropion
- Calcium 600 D (calcium / vitamin d)
- carvedilol
- Cialis (tadalafil)
- clopidogrel
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- cyclobenzaprine
- gabapentin
- gemfibrozil
- Levemir (insulin detemir)
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- metformin
- metoprolol
- Metoprolol Tartrate (metoprolol)
- Norvasc (amlodipine)
- omeprazole
- simvastatin
- tramadol
- Vitamin D3 (cholecalciferol)
Aspir-Mox IB alcohol/food interactions
There are 4 alcohol/food interactions with Aspir-Mox IB (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide).
Aspir-Mox IB disease interactions
There are 18 disease interactions with Aspir-Mox IB (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide) which include:
- constipation
- coagulation
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about Aspir-Mox IB (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.